To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Nuclear factor of activated T cells cytoplasmic calcineurin-dependent 1 (NFATc1); interleukin-10 (IL-10)

Autoimmune disease

INDICATION: Psoriasis

Mouse studies suggest inhibiting NFATc1 could help treat

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE